Financhill
Buy
77

KMI Quote, Financials, Valuation and Earnings

Last price:
$28.65
Seasonality move :
0.05%
Day range:
$28.09 - $28.66
52-week range:
$17.61 - $31.48
Dividend yield:
4.02%
P/E ratio:
24.47x
P/S ratio:
4.21x
P/B ratio:
2.08x
Volume:
8.7M
Avg. volume:
12.9M
1-year change:
55.51%
Market cap:
$63.6B
Revenue:
$15.1B
EPS (TTM):
$1.17
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue $11.7B $16.6B $19.2B $15.3B $15.1B
Revenue Growth (YoY) -11.42% 41.97% 15.59% -20.14% -1.53%
 
Cost of Revenues $4.7B $8.6B $11.4B $7.2B $6.7B
Gross Profit $7B $8B $7.8B $8.1B $8.4B
Gross Profit Margin 59.75% 48.06% 40.41% 53.12% 55.69%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $648M $655M $637M $668M $712M
Other Inc / (Exp) -$1.2B -$829M $783M $735M $867M
Operating Expenses $3.5B $3.4B $3.7B $3.9B $4B
Operating Income $3.5B $4.5B $4.1B $4.3B $4.4B
 
Net Interest Expenses $1.6B $1.5B $1.5B $1.8B $1.8B
EBT. Incl. Unusual Items $661M $2.2B $3.3B $3.2B $3.4B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $481M $369M $710M $715M $687M
Net Income to Company $180M $1.9B $2.6B $2.5B $2.7B
 
Minority Interest in Earnings -$61M -$66M -$77M -$95M -$107M
Net Income to Common Excl Extra Items $119M $1.8B $2.5B $2.4B $2.6B
 
Basic EPS (Cont. Ops) $0.05 $0.78 $1.12 $1.06 $1.17
Diluted EPS (Cont. Ops) $0.05 $0.78 $1.12 $1.06 $1.17
Weighted Average Basic Share $2.3B $2.3B $2.3B $2.2B $2.2B
Weighted Average Diluted Share $2.3B $2.3B $2.3B $2.2B $2.2B
 
EBITDA $5.7B $6.7B $6.3B $6.5B $6.7B
EBIT $3.5B $4.5B $4.1B $4.3B $4.4B
 
Revenue (Reported) $11.7B $16.6B $19.2B $15.3B $15.1B
Operating Income (Reported) $3.5B $4.5B $4.1B $4.3B $4.4B
Operating Income (Adjusted) $3.5B $4.5B $4.1B $4.3B $4.4B
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue $3.1B $4.4B $4.6B $4B $4B
Revenue Growth (YoY) -7.07% 42.06% 3.48% -11.82% -1.26%
 
Cost of Revenues $1.3B $2.5B $2.5B $1.9B $1.8B
Gross Profit $1.8B $1.9B $2.1B $2.1B $2.2B
Gross Profit Margin 57.82% 42.85% 45.08% 52.6% 53.98%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $187M $165M $167M $171M $182M
Other Inc / (Exp) $256M $173M $183M $159M $149M
Operating Expenses $876M $924M $930M $1B $968M
Operating Income $925M $972M $1.1B $1.1B $1.2B
 
Net Interest Expenses $381M $370M $426M $452M $442M
EBT. Incl. Unusual Items $800M $775M $891M $824M $891M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $177M $121M $198M $206M $197M
Net Income to Company $623M $654M $693M $618M $694M
 
Minority Interest in Earnings -$16M -$17M -$23M -$24M -$27M
Net Income to Common Excl Extra Items $607M $637M $670M $594M $667M
 
Basic EPS (Cont. Ops) $0.27 $0.28 $0.30 $0.27 $0.30
Diluted EPS (Cont. Ops) $0.27 $0.28 $0.30 $0.27 $0.30
Weighted Average Basic Share $2.3B $2.3B $2.2B $2.2B $2.2B
Weighted Average Diluted Share $2.3B $2.3B $2.2B $2.2B $2.2B
 
EBITDA $1.5B $1.5B $1.7B $1.7B $1.8B
EBIT $925M $972M $1.1B $1.1B $1.2B
 
Revenue (Reported) $3.1B $4.4B $4.6B $4B $4B
Operating Income (Reported) $925M $972M $1.1B $1.1B $1.2B
Operating Income (Adjusted) $925M $972M $1.1B $1.1B $1.2B
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue $11.7B $16.6B $19.2B $15.3B $15.1B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $4.7B $8.6B $11.4B $7.2B $6.7B
Gross Profit $7B $8B $7.8B $8.1B $8.4B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $648M $655M $637M $668M $712M
Other Inc / (Exp) -$1.2B -$829M $783M $735M $867M
Operating Expenses $3.5B $3.4B $3.7B $3.9B $4B
Operating Income $3.5B $4.5B $4.1B $4.3B $4.4B
 
Net Interest Expenses $1.6B $1.5B $1.5B $1.8B $1.8B
EBT. Incl. Unusual Items $661M $2.2B $3.3B $3.2B $3.4B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $481M $369M $710M $715M $687M
Net Income to Company $180M $1.9B $2.6B $2.5B $2.7B
 
Minority Interest in Earnings -$61M -$66M -$77M -$95M -$107M
Net Income to Common Excl Extra Items $119M $1.8B $2.5B $2.4B $2.6B
 
Basic EPS (Cont. Ops) $0.05 $0.78 $1.12 $1.07 $1.17
Diluted EPS (Cont. Ops) $0.05 $0.78 $1.12 $1.07 $1.17
Weighted Average Basic Share
Weighted Average Diluted Share
 
EBITDA $5.7B $6.7B $6.3B $6.5B $6.7B
EBIT $3.5B $4.5B $4.1B $4.3B $4.4B
 
Revenue (Reported) $11.7B $16.6B $19.2B $15.3B $15.1B
Operating Income (Reported) $3.5B $4.5B $4.1B $4.3B $4.4B
Operating Income (Adjusted) $3.5B $4.5B $4.1B $4.3B $4.4B
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Revenue $16.6B $19.2B $15.3B $15.1B --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $8.6B $11.4B $7.2B $6.7B --
Gross Profit $8B $7.8B $8.1B $8.4B --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $655M $637M $668M $712M --
Other Inc / (Exp) -$829M $783M $735M $867M --
Operating Expenses $3.4B $3.7B $3.9B $4B --
Operating Income $4.5B $4.1B $4.3B $4.4B --
 
Net Interest Expenses $1.5B $1.5B $1.8B $1.8B --
EBT. Incl. Unusual Items $2.2B $3.3B $3.2B $3.4B --
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $369M $710M $715M $687M --
Net Income to Company $1.9B $2.6B $2.5B $2.7B --
 
Minority Interest in Earnings -$66M -$77M -$95M -$107M --
Net Income to Common Excl Extra Items $1.8B $2.5B $2.4B $2.6B --
 
Basic EPS (Cont. Ops) $0.78 $1.12 $1.07 $1.17 --
Diluted EPS (Cont. Ops) $0.78 $1.12 $1.07 $1.17 --
Weighted Average Basic Share $9.1B $9B $8.9B $8.9B --
Weighted Average Diluted Share $9.1B $9B $8.9B $8.9B --
 
EBITDA $6.7B $6.3B $6.5B $6.7B --
EBIT $4.5B $4.1B $4.3B $4.4B --
 
Revenue (Reported) $16.6B $19.2B $15.3B $15.1B --
Operating Income (Reported) $4.5B $4.1B $4.3B $4.4B --
Operating Income (Adjusted) $4.5B $4.1B $4.3B $4.4B --
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Cash and Equivalents $1.2B $1.1B $745M $83M $88M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $1.3B $1.6B $1.8B $1.6B $1.5B
Inventory $348M $562M $634M $525M $555M
Prepaid Expenses -- -- -- -- --
Other Current Assets $168M $289M $304M $333M $246M
Total Current Assets $3.2B $3.8B $3.8B $2.5B $2.5B
 
Property Plant And Equipment $35.8B $35.7B $35.6B $37.3B $38B
Long-Term Investments $7.9B $7.6B $7.7B $7.9B $7.8B
Goodwill $19.9B $19.9B $20B $20.1B $20.1B
Other Intangibles $2.5B $1.7B $1.8B $2B $1.8B
Other Long-Term Assets $2.2B $1.6B $1.2B $1.2B $1.2B
Total Assets $72B $70.4B $70.1B $71B $71.4B
 
Accounts Payable $837M $1.3B $1.4B $1.4B $1.4B
Accrued Expenses $832M $504M $515M $513M $543M
Current Portion Of Long-Term Debt $2.6B $2.6B $3.4B $4B $2B
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities $580M $1.1B $1.3B $1B $878M
Total Current Liabilities $5.1B $5.8B $6.9B $7.2B $5.1B
 
Long-Term Debt $32B $30.6B $28.2B $27.8B $29.7B
Capital Leases -- -- -- -- --
Total Liabilities $39.4B $38.5B $38B $39.3B $39.5B
 
Common Stock $23M $23M $22M $22M $22M
Other Common Equity Adj -$407M -$411M -$402M -$217M -$95M
Common Equity $31.4B $30.8B $30.7B $30.3B $30.5B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $1.1B $1.1B $1.4B $1.4B $1.3B
Total Equity $32.6B $31.9B $32.1B $31.7B $31.9B
 
Total Liabilities and Equity $72B $70.4B $70.1B $71B $71.4B
Cash and Short Terms $1.2B $1.1B $745M $83M $88M
Total Debt $34.6B $33.2B $31.6B $31.9B $31.7B
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Cash and Equivalents $1.2B $1.1B $745M $83M $88M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $1.3B $1.6B $1.8B $1.6B $1.5B
Inventory $348M $562M $634M $525M $555M
Prepaid Expenses -- -- -- -- --
Other Current Assets $168M $289M $304M $333M $246M
Total Current Assets $3.2B $3.8B $3.8B $2.5B $2.5B
 
Property Plant And Equipment $35.8B $35.7B $35.6B $37.3B $38B
Long-Term Investments $7.9B $7.6B $7.7B $7.9B $7.8B
Goodwill $19.9B $19.9B $20B $20.1B $20.1B
Other Intangibles $2.5B $1.7B $1.8B $2B $1.8B
Other Long-Term Assets $2.2B $1.6B $1.2B $1.2B $1.2B
Total Assets $72B $70.4B $70.1B $71B $71.4B
 
Accounts Payable $837M $1.3B $1.4B $1.4B $1.4B
Accrued Expenses $832M $504M $515M $513M $543M
Current Portion Of Long-Term Debt $2.6B $2.6B $3.4B $4B $2B
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities $580M $1.1B $1.3B $1B $878M
Total Current Liabilities $5.1B $5.8B $6.9B $7.2B $5.1B
 
Long-Term Debt $32B $30.6B $28.2B $27.8B $29.7B
Capital Leases -- -- -- -- --
Total Liabilities $39.4B $38.5B $38B $39.3B $39.5B
 
Common Stock $23M $23M $22M $22M $22M
Other Common Equity Adj -$407M -$411M -$402M -$217M -$95M
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $1.1B $1.1B $1.4B $1.4B $1.3B
Total Equity $32.6B $31.9B $32.1B $31.7B $31.9B
 
Total Liabilities and Equity $72B $70.4B $70.1B $71B $71.4B
Cash and Short Terms $1.2B $1.1B $745M $83M $88M
Total Debt $34.6B $33.2B $31.6B $31.9B $31.7B
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Net Income to Stockholders $180M $1.9B $2.6B $2.5B $2.7B
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable $88M -$265M -$220M $301M $52M
Change in Inventories $16M -$202M -$183M $188M -$12M
Cash From Operations $4.6B $5.7B $5B $6.5B $5.6B
 
Capital Expenditures $1.7B $1.3B $1.6B $2.3B $2.6B
Cash Acquisitions -- -$1.5B -$487M -$1.8B -$62M
Cash From Investing -$911M -$2.3B -$2.2B -$4.2B -$2.6B
 
Dividends Paid (Ex Special Dividend) -$2.4B -$2.5B -$2.5B -$2.5B -$2.6B
Special Dividend Paid
Long-Term Debt Issued $3.9B $6B $9.1B $7.6B $10.4B
Long-Term Debt Repaid -$4B -$6.8B -$9.7B -$7.4B -$10.6B
Repurchase of Common Stock -$50M -- -$368M -$522M -$7M
Other Financing Activities -$39M -$68M $404M -$197M -$207M
Cash From Financing -$2.6B -$3.5B -$3.1B -$3B -$2.9B
 
Beginning Cash (CF) $209M $1.2B $1.1B $794M $96M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $1B -$62M -$353M -$698M $119M
Ending Cash (CF) $1.2B $1.1B $794M $96M $214M
 
Levered Free Cash Flow $2.8B $4.4B $3.3B $4.2B $3B
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Net Income to Stockholders $623M $654M $693M $618M $694M
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -$150M -$146M $40M -$50M -$248M
Change in Inventories -$25M -$113M -$18M $58M -$14M
Cash From Operations $1.3B $1.3B $1.4B $2.3B $1.5B
 
Capital Expenditures $356M $387M $477M $628M $772M
Cash Acquisitions -- -$446M $1M -- --
Cash From Investing -$135M -$394M -$630M -$2.4B -$771M
 
Dividends Paid (Ex Special Dividend) -$617M -$630M -$628M -$631M -$642M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- $1B $160M $3.2B $1.6B
Long-Term Debt Repaid -$5M -$372M -$166M -$2.3B -$1.6B
Repurchase of Common Stock -- -- -$35M -$132M --
Other Financing Activities -$3M -$13M -$34M -$30M -$33M
Cash From Financing -$625M -$6M -$703M $119M -$657M
 
Beginning Cash (CF) $699M $279M $723M $97M $133M
Foreign Exchange Rate Adjustment $2M -- -- -- --
Additions / Reductions $508M $868M $71M -$1M $82M
Ending Cash (CF) $1.2B $1.1B $794M $96M $214M
 
Levered Free Cash Flow $912M $881M $927M $1.7B $738M
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Net Income to Stockholders $180M $1.9B $2.6B $2.5B $2.7B
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable $88M -$265M -$220M $301M $52M
Change in Inventories $16M -$202M -$183M $188M -$12M
Cash From Operations $4.6B $5.7B $5B $6.5B $5.6B
 
Capital Expenditures $1.7B $1.3B $1.6B $2.3B $2.6B
Cash Acquisitions -- -$1.5B -$487M -- --
Cash From Investing -$911M -$2.3B -$2.2B -$4.2B -$2.6B
 
Dividends Paid (Ex Special Dividend) -$2.4B -$2.5B -$2.5B -$2.5B -$2.6B
Special Dividend Paid
Long-Term Debt Issued $3.9B $6B $9.1B $7.6B $10.4B
Long-Term Debt Repaid -$4B -$6.8B -$9.7B -$7.4B -$10.6B
Repurchase of Common Stock -$50M -- -$368M -$522M -$7M
Other Financing Activities -$39M -$68M $404M -$197M -$207M
Cash From Financing -$2.6B -$3.5B -$3.1B -$3B -$2.9B
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $1B -$62M -$353M -$698M $119M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $2.8B $4.4B $3.3B $4.2B $3B
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Net Income to Stockholders $1.9B $2.6B $2.5B $2.7B --
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -$265M -$220M $301M $52M --
Change in Inventories -$202M -$183M $188M -$12M --
Cash From Operations $5.7B $5B $6.5B $5.6B --
 
Capital Expenditures $1.3B $1.6B $2.3B $2.6B --
Cash Acquisitions -$1.5B -$487M -- -- --
Cash From Investing -$2.3B -$2.2B -$4.2B -$2.6B --
 
Dividends Paid (Ex Special Dividend) -$2.5B -$2.5B -$2.5B -$2.6B --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $6B $9.1B $7.6B $10.4B --
Long-Term Debt Repaid -$6.8B -$9.7B -$7.4B -$10.6B --
Repurchase of Common Stock -- -$368M -$522M -$7M --
Other Financing Activities -$68M $404M -$197M -$207M --
Cash From Financing -$3.5B -$3.1B -$3B -$2.9B --
 
Beginning Cash (CF) $4.9B $2.6B $1.8B $496M --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$62M -$353M -$698M $119M --
Ending Cash (CF) $4.8B $2.3B $1.2B $614M --
 
Levered Free Cash Flow $4.4B $3.3B $4.2B $3B --

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is it Too Late to Buy United Airlines Stock?
Is it Too Late to Buy United Airlines Stock?

United Airlines (NASDAQ:UAL) has thoroughly outpaced the broader stock market…

3 Smartest Dividend Stocks to Buy Now
3 Smartest Dividend Stocks to Buy Now

When the market entered a correction in February and March,…

How High Could IBIT Go?
How High Could IBIT Go?

Recently, a surprising number of billionaire hedge fund managers have…

Stock Ideas

Buy
56
Is AAPL Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 37x

Sell
46
Is MSFT Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 32x

Sell
42
Is NVDA Stock a Buy?

Market Cap: $2.7T
P/E Ratio: 37x

Alerts

Buy
100
DLICY alert for Apr 2

Dai-ichi Life Holdings [DLICY] is up 100.91% over the past day.

Buy
78
GATE alert for Apr 2

Marblegate Acquisition [GATE] is up 86.64% over the past day.

Sell
15
PCVX alert for Apr 2

Vaxcyte [PCVX] is down 14.62% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock